Literature DB >> 15555779

Splice variants of the receptor for advanced glycosylation end products (RAGE) in human brain.

Qunxing Ding1, Jeffrey N Keller.   

Abstract

Previous studies indicate that the receptor for advanced glycosylation end products (RAGE) plays an important role in multiple pathological processes, including Alzheimer's disease. Currently there are three established isoforms of the RAGE receptor, with each isoform generated as the result of alternative splicing. It is presently unclear which of the RAGE isoforms are normally expressed in the human brain, nor has it been determined if additional RAGE isoforms exist in the human brain. In the present study we demonstrate for the first time that each of the three established RAGE isoforms, as well as three previously unidentified RAGE splicing variants, are normally expressed in the human brain. These data suggest that RAGE may have multiple functions in the human brain, mediated by the individual or coordinated efforts of the different RAGE isoforms, with alternative splicing generating individual RAGE isoforms that specifically interact with the various ligands present in the brain.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15555779     DOI: 10.1016/j.neulet.2004.09.059

Source DB:  PubMed          Journal:  Neurosci Lett        ISSN: 0304-3940            Impact factor:   3.046


  26 in total

Review 1.  S100 proteins in cartilage: role in arthritis.

Authors:  Raghunatha R Yammani
Journal:  Biochim Biophys Acta       Date:  2012-01-12

2.  The effects of the receptor for advanced glycation end products (RAGE) on bone metabolism under physiological and diabetic conditions.

Authors:  Yasuhiro Hamada; Sohei Kitazawa; Riko Kitazawa; Keiji Kono; Shunsuke Goto; Hirotaka Komaba; Hideki Fujii; Yasuhiko Yamamoto; Hiroshi Yamamoto; Makoto Usami; Masafumi Fukagawa
Journal:  Endocrine       Date:  2010-10-23       Impact factor: 3.633

3.  Adipose stem cells' antagonism in glycosylation of D-galactose-induced skin aging of nude mice and its skin recovery function.

Authors:  Haiying Wang; Shuyue Wei; Xinxin Xue; Yuntian You; Qiang Ma
Journal:  Int J Immunopathol Pharmacol       Date:  2016-02-25       Impact factor: 3.219

4.  A multicellular signal transduction network of AGE/RAGE signaling.

Authors:  Sowmya Soman; Rajesh Raju; Varot K Sandhya; Jayshree Advani; Aafaque Ahmad Khan; H C Harsha; T S Keshava Prasad; P R Sudhakaran; Akhilesh Pandey; Puneeth K Adishesha
Journal:  J Cell Commun Signal       Date:  2012-11-19       Impact factor: 5.782

5.  Endogenous Secretory RAGE as a Novel Biomarker for Metabolic Syndrome and Cardiovascular Diseases.

Authors:  Hidenori Koyama; Hiroshi Yamamoto; Yoshiki Nishizawa
Journal:  Biomark Insights       Date:  2007-09-17

6.  Association of the RAGE G82S polymorphism with Alzheimer's disease.

Authors:  Jonny Daborg; Malin von Otter; Annica Sjölander; Staffan Nilsson; Lennart Minthon; Deborah R Gustafson; Ingmar Skoog; Kaj Blennow; Henrik Zetterberg
Journal:  J Neural Transm (Vienna)       Date:  2010-06-22       Impact factor: 3.575

7.  Precursor of advanced glycation end products mediates ER-stress-induced caspase-3 activation of human dermal fibroblasts through NAD(P)H oxidase 4.

Authors:  Danielle T Loughlin; Carol M Artlett
Journal:  PLoS One       Date:  2010-06-14       Impact factor: 3.240

8.  The S100B/RAGE Axis in Alzheimer's Disease.

Authors:  Estelle Leclerc; Emmanuel Sturchler; Stefan W Vetter
Journal:  Cardiovasc Psychiatry Neurol       Date:  2010-06-21

9.  Receptor for advanced glycation end products: its role in Alzheimer's disease and other neurological diseases.

Authors:  Lih-Fen Lue; Douglas Gordon Walker; Sandra Jacobson; Marwan Sabbagh
Journal:  Future Neurol       Date:  2009

Review 10.  The HMGB1-RAGE Inflammatory Pathway: Implications for Brain Injury-Induced Pulmonary Dysfunction.

Authors:  Daniel J Weber; Yohance M Allette; David S Wilkes; Fletcher A White
Journal:  Antioxid Redox Signal       Date:  2015-05-14       Impact factor: 8.401

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.